CLINICAL_TRIALS
trial_result
· 2023-02-16
Clinical Trial Update: A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients [Phase 2]
Summary
Phase 2 study of orally administered JBPOS0101 in refractory infantile spasms was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bio-Pharm Solutions Co., Ltd. | Conditions: Refractory Infantile Spasms | Phase 2 | Status: TERMINATED | Results posted: 2023-02-16